Antibiotic use during severe RSV bronchiolitis may increase subsequent recurrent wheeze risk
A. Beigelman (Petah Tikva, Israel), M. Srinivasan (St. Louis, United States), C. Goss (St. Louis, United States), J. Wang (St. Louis, United States), Y. Zhou (Farmington, United States), K. True (St. Louis, United States), E. Ahrens (St. Louis, United States), D. Burgdorf (St. Louis, United States), M. Haslam (St. Louis, United States), J. Boomer (Kansas City, United States), S. Bram (St. Louis, United States), C. Burnham (St. Louis, United States), T. Casper (St. Louis, United States), A. Coverstone (St. Louis, United States), W. Kanchongkittiphon (Bangkok, Thailand), C. Kuklinski (St. Louis, United States), G. Storch (St. Louis, United States), M. Wallace (St. Louis, United States), H. Yin-Declue (Kansas City, United States), M. Castro (Kansas City, United States), K. Schechtman (St. Louis, United States), L. Bacharier (Nashville, United States)
Source: International Congress 2022 – ALERT 2: Digital and paediatric
Session: ALERT 2: Digital and paediatric
Session type: Clinical trials session
Number: 2164
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Beigelman (Petah Tikva, Israel), M. Srinivasan (St. Louis, United States), C. Goss (St. Louis, United States), J. Wang (St. Louis, United States), Y. Zhou (Farmington, United States), K. True (St. Louis, United States), E. Ahrens (St. Louis, United States), D. Burgdorf (St. Louis, United States), M. Haslam (St. Louis, United States), J. Boomer (Kansas City, United States), S. Bram (St. Louis, United States), C. Burnham (St. Louis, United States), T. Casper (St. Louis, United States), A. Coverstone (St. Louis, United States), W. Kanchongkittiphon (Bangkok, Thailand), C. Kuklinski (St. Louis, United States), G. Storch (St. Louis, United States), M. Wallace (St. Louis, United States), H. Yin-Declue (Kansas City, United States), M. Castro (Kansas City, United States), K. Schechtman (St. Louis, United States), L. Bacharier (Nashville, United States). Antibiotic use during severe RSV bronchiolitis may increase subsequent recurrent wheeze risk. 2164
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|